Loading…
Effect of embelin on inhibition of cell growth and induction of apoptosis in Acanthamoeba castellanii
Acanthamoeba castellanii is the causative agent of fatal encephalitis and blinding keratitis. Current therapies remain a challenge, hence there is a need to search for new therapeutics. Here, we tested embelin (EMB) and silver nanoparticles doped with embelin (EMB–AgNPs) against A. castellanii . Usi...
Saved in:
Published in: | Archives of microbiology 2023-11, Vol.205 (12), p.360-360, Article 360 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Acanthamoeba castellanii
is the causative agent of fatal encephalitis and blinding keratitis. Current therapies remain a challenge, hence there is a need to search for new therapeutics. Here, we tested embelin (EMB) and silver nanoparticles doped with embelin (EMB–AgNPs) against
A. castellanii
. Using amoebicidal assays, the results revealed that both compounds inhibited the viability of
Acanthamoeba
, having an IC
50
of 27.16 ± 0.63 and 13.63 ± 1.08 μM, respectively, while causing minimal cytotoxicity against HaCaT cells in vitro. The findings suggest that both samples induced apoptosis through the mitochondria-mediated pathway. Differentially expressed genes analysis showed that 652 genes were uniquely expressed in treated versus untreated cells, out of which 191 were significantly regulated in the negative control vs. conjugate. Combining the analysis, seven genes (
ARIH1
,
RAP1
,
H3
,
SDR16C5
,
GST
,
SRX1,
and
PFN
) were highlighted as the most significant (Log2 (FC) value ± 4) for the molecular mode of action in vitro. The KEGG analysis linked most of the genes to apoptosis, the oxidative stress signaling pathway, cytochrome P450, Rap1, and the oxytocin signaling pathways. In summary, this study provides a thorough framework for developing therapeutic agents against microbial infections using EMB and EMB–AgNPs.
Graphical abstract |
---|---|
ISSN: | 0302-8933 1432-072X |
DOI: | 10.1007/s00203-023-03698-3 |